 | • レポートコード：MRC2012A4993 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザワクチンの種類別市場規模（全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン）、用途別市場規模（子供（6ヶ月〜3歳）、大人・3歳以上子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：CSL、Mylan、GSK、Johnson & Johnson、Sanofi Pasteur、Pfizer、AstraZeneca、 ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザワクチンの北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザワクチンの南米市場（ブラジル、アルゼンチン） ・インフルエンザワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン ・用途別分析：子供（6ヶ月〜3歳）、大人・3歳以上子供 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Influenza Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Influenza Vaccine market has been segmented into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
By Application, Influenza Vaccine has been segmented into:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Influenza Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Influenza Vaccine Market Share Analysis
Influenza Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenza Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Influenza Vaccine are:
CSL
Mylan
GSK
Johnson & Johnson
Sanofi Pasteur
Pfizer
AstraZeneca
Among other players domestic and global, Influenza Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales, revenue and global market share of Influenza Vaccine in 2018 and 2019.
Chapter 3, the Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Overview of Global Influenza Vaccine Market
1.4.1 Global Influenza Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL SWOT Analysis
2.1.4 CSL Product and Services
2.1.5 CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi Pasteur
2.5.1 Sanofi Pasteur Details
2.5.2 Sanofi Pasteur Major Business
2.5.3 Sanofi Pasteur SWOT Analysis
2.5.4 Sanofi Pasteur Product and Services
2.5.5 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Product and Services
2.6.4 Pfizer Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Product and Services
2.7.4 AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Influenza Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Influenza Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Influenza Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Influenza Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Influenza Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenza Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Influenza Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Influenza Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Influenza Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Influenza Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenza Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Influenza Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Influenza Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Influenza Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Influenza Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Influenza Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Influenza Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Influenza Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Influenza Vaccine Sales and Growth Rate (2015-2020)
6.4 France Influenza Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Influenza Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Influenza Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenza Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Influenza Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Influenza Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Influenza Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Influenza Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Influenza Vaccine Sales and Growth Rate (2015-2020)
7.5 India Influenza Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Influenza Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Influenza Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Influenza Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Influenza Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Influenza Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Influenza Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Influenza Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenza Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Influenza Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Influenza Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Influenza Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Influenza Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Influenza Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Influenza Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Influenza Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Influenza Vaccine Price by Type (2015-2020)
11 Global Influenza Vaccine Market Segment by Application
11.1 Global Influenza Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Influenza Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Influenza Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Influenza Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Influenza Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Influenza Vaccine Market Forecast (2021-2025)
12.2.2 Europe Influenza Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Influenza Vaccine Market Forecast (2021-2025)
12.2.4 South America Influenza Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Influenza Vaccine Market Forecast (2021-2025)
12.3 Influenza Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Influenza Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Influenza Vaccine Market Share Forecast by Type (2021-2025)
12.4 Influenza Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Influenza Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Influenza Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Influenza Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Influenza Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Influenza Vaccine Major Business
Table 10. CSL Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. CSL SWOT Analysis
Table 12. CSL Influenza Vaccine Product and Services
Table 13. CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mylan Basic Information, Manufacturing Base and Competitors
Table 15. Mylan Influenza Vaccine Major Business
Table 16. Mylan Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Mylan SWOT Analysis
Table 18. Mylan Influenza Vaccine Product and Services
Table 19. Mylan Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. GSK Basic Information, Manufacturing Base and Competitors
Table 21. GSK Influenza Vaccine Major Business
Table 22. GSK Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. GSK SWOT Analysis
Table 24. GSK Influenza Vaccine Product and Services
Table 25. GSK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 27. Johnson & Johnson Influenza Vaccine Major Business
Table 28. Johnson & Johnson Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. Johnson & Johnson SWOT Analysis
Table 30. Johnson & Johnson Influenza Vaccine Product and Services
Table 31. Johnson & Johnson Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 33. Sanofi Pasteur Influenza Vaccine Major Business
Table 34. Sanofi Pasteur Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. Sanofi Pasteur SWOT Analysis
Table 36. Sanofi Pasteur Influenza Vaccine Product and Services
Table 37. Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Influenza Vaccine Major Business
Table 40. Pfizer Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Pfizer SWOT Analysis
Table 42. Pfizer Influenza Vaccine Product and Services
Table 43. Pfizer Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 45. AstraZeneca Influenza Vaccine Major Business
Table 46. AstraZeneca Influenza Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. AstraZeneca SWOT Analysis
Table 48. AstraZeneca Influenza Vaccine Product and Services
Table 49. AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Influenza Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 51. Global Influenza Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Influenza Vaccine Sales by Regions (2015-2020) (K Doses)
Table 53. Global Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 54. Global Influenza Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 56. North America Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 57. North America Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 59. Europe Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 60. Europe Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 61. Europe Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Influenza Vaccine Sales by Regions (2015-2020) (K Doses)
Table 63. Asia-Pacific Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Influenza Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 66. South America Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 67. South America Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 70. Middle East & Africa Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 73. Global Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 74. Global Influenza Vaccine Sales Share by Type (2015-2020)
Table 75. Global Influenza Vaccine Revenue by Type (2015-2020) (USD Million)
Table 76. Global Influenza Vaccine Revenue Share by Type (2015-2020)
Table 77. Global Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 78. Global Influenza Vaccine Sales Share by Application (2015-2020)
Table 79. Global Influenza Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 80. Global Influenza Vaccine Market Share Forecast by Regions (2021-2025)
Table 81. Global Influenza Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 82. Global Influenza Vaccine Market Share Forecast by Type (2021-2025)
Table 83. Global Influenza Vaccine Sales Forecast by Application (2021-2025)
Table 84. Global Influenza Vaccine Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Influenza Vaccine Picture
Figure 2. Global Sales Market Share of Influenza Vaccine by Type in 2019
Figure 3. Whole Virus Vaccines Picture
Figure 4. Split Virus Vaccines Picture
Figure 5. Subunit Vaccines Picture
Figure 6. Live Attenuated Virus Vaccines Picture
Figure 7. Influenza Vaccine Sales Market Share by Application in 2019
Figure 8. For Children (6 months to 3 years) Picture
Figure 9. For Adults and Children over 3 years Picture
Figure 10. Global Influenza Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Influenza Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Influenza Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Influenza Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Influenza Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 36. Global Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Influenza Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Influenza Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Influenza Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Influenza Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Influenza Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Influenza Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Canada Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Mexico Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Europe Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. UK Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. France Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Italy Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Asia-Pacific Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Influenza Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Influenza Vaccine Revenue Market Share by Regions 2019
Figure 63. China Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Korea Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. India Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Southeast Asia Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. South America Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Influenza Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Middle East and Africa Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Influenza Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Egypt Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Turkey Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. South Africa Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Global Influenza Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 82. Global Influenza Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. Europe Sales Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. Asia-Pacific Sales Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. South America Sales Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. Middle East & Africa Sales Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…- A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza A Virus, …
- 豚インフルエンザワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Swine Influenza Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Swine Influenza Vacc…
- 水痘生ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Varicella Virus Vaccine Live market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Varicella Virus …
- アヒルウイルス腸炎ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Duck Virus Enteritis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Duck Virus Enter…